Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(3-(2-methylsulfonylphenothiazin-10-yl) Propyl)isonipecotinamide
2. Metopimazine Hydrochloride
3. Vogalene
1. 14008-44-7
2. Vogalene
3. Exp 999
4. 1-[3-(2-methylsulfonylphenothiazin-10-yl)propyl]piperidine-4-carboxamide
5. Exp-999
6. 4-piperidinecarboxamide, 1-[3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl]-
7. 1-(3-(2-(methylsulfonyl)phenothiazin-10-yl)propyl)isonipecotamide
8. 238s75v9av
9. 4-piperidinecarboxamide, 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)-
10. Rp-9965
11. Nortrip
12. 1-[3-[2-(methylsulfonyl)phenothiazin-10-yl]propyl]isonipecotamide
13. 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)-4-piperidinecarboxamide
14. 1-[3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl]-4-piperidinecarboxamide
15. Metopimazina
16. Metopimazinum
17. Metopimazinum [inn-latin]
18. Metopimazina [inn-spanish]
19. Rp 9965
20. Einecs 237-818-4
21. Brn 4278585
22. Unii-238s75v9av
23. Metopimazine [usan:inn:ban]
24. 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)piperidin-4-carboxamide
25. 1-[3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl]piperidin-4-carboxamide
26. 2-methylsulfonyl-10-(3-(4-carbamoylpiperidino)propyl)phenothiazine
27. Metopimazine [mi]
28. 10-(3-(4-carbamoylpiperidine)propyl)-2-(methanesulfonyl)phenothiazine
29. Phenothiazine, 10-(3-(4'-carbamoylpiperidino)propyl)-2-methylsulfonyl-
30. Metopimazine (usan/inn)
31. Metopimazine [inn]
32. 1-(3-(2-(methylsulfonyl)phenothiazin-10-yl)propyl)-4-piperidinecarboxamide
33. 4-piperidinecarboxamide, 1-(3-(2-(methanesulfonyl)phenothiazin-10-yl)propyl)-
34. Metopimazine [usan]
35. Schembl49905
36. Metopimazine [mart.]
37. Metopimazine [who-dd]
38. Chembl398615
39. Bdbm82383
40. Gtpl11140
41. Dtxsid80161224
42. Chebi:135726
43. Bdbm179867
44. Zinc537996
45. Cas_26388
46. Ng-101
47. Nsc_26388
48. Akos005065914
49. Isonipecotamide, 1-(3-(2-(methylsulfonyl)phenothiazin-10-yl)propyl)-
50. Bcp9000921
51. Db13591
52. Us9132134, Metopimazine (ng101)
53. Ft-0672379
54. Ft-0672380
55. D05010
56. Q194682
57. J-007351
58. 1-(3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl)-4-piperidinecarboxamide #
Molecular Weight | 445.6 g/mol |
---|---|
Molecular Formula | C22H27N3O3S2 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 445.14938408 g/mol |
Monoisotopic Mass | 445.14938408 g/mol |
Topological Polar Surface Area | 117 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 703 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
A - Alimentary tract and metabolism
A04 - Antiemetics and antinauseants
A04A - Antiemetics and antinauseants
A04AD - Other antiemetics
A04AD05 - Metopimazine
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Metopimazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metopimazine manufacturer or Metopimazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metopimazine manufacturer or Metopimazine supplier.
PharmaCompass also assists you with knowing the Metopimazine API Price utilized in the formulation of products. Metopimazine API Price is not always fixed or binding as the Metopimazine Price is obtained through a variety of data sources. The Metopimazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vogalene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vogalene, including repackagers and relabelers. The FDA regulates Vogalene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vogalene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vogalene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vogalene supplier is an individual or a company that provides Vogalene active pharmaceutical ingredient (API) or Vogalene finished formulations upon request. The Vogalene suppliers may include Vogalene API manufacturers, exporters, distributors and traders.
click here to find a list of Vogalene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vogalene DMF (Drug Master File) is a document detailing the whole manufacturing process of Vogalene active pharmaceutical ingredient (API) in detail. Different forms of Vogalene DMFs exist exist since differing nations have different regulations, such as Vogalene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vogalene DMF submitted to regulatory agencies in the US is known as a USDMF. Vogalene USDMF includes data on Vogalene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vogalene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vogalene suppliers with USDMF on PharmaCompass.
A Vogalene written confirmation (Vogalene WC) is an official document issued by a regulatory agency to a Vogalene manufacturer, verifying that the manufacturing facility of a Vogalene active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vogalene APIs or Vogalene finished pharmaceutical products to another nation, regulatory agencies frequently require a Vogalene WC (written confirmation) as part of the regulatory process.
click here to find a list of Vogalene suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vogalene as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vogalene API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vogalene as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vogalene and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vogalene NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vogalene suppliers with NDC on PharmaCompass.
Vogalene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vogalene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vogalene GMP manufacturer or Vogalene GMP API supplier for your needs.
A Vogalene CoA (Certificate of Analysis) is a formal document that attests to Vogalene's compliance with Vogalene specifications and serves as a tool for batch-level quality control.
Vogalene CoA mostly includes findings from lab analyses of a specific batch. For each Vogalene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vogalene may be tested according to a variety of international standards, such as European Pharmacopoeia (Vogalene EP), Vogalene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vogalene USP).